VEEV
NYSEVEEVA SYSTEMS INC
Health Care, Health Care Technology
$230.47
close 7 Aug 2026
-16.79%
52-week change
$37.05B
market cap
$148.05
$310.50
52-week range
Expected price
Expected price
$310.36 – $379.33
Current price
$230.47
Signal
Could be undervalued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
P/E (TTM)40.86x
P/S (TTM)11.16x
P/B5.07x
EV/EBITDA (TTM)—
FCF yield (TTM)4.43%
PEG (TTM, GAAP)1.86
Context
P/E, own 5-year average62.42x
P/E, sector median29.65x*
Price at 5-year median P/E$341.28*
Forward — analyst consensus
Forward P/E (FY2027)25.43x*
Forward P/E (FY2028)22.97x
Forward PEG2.37*
Consensus EPS FY2027 (26 analysts)$9.06
EPS growth (FY2027→FY2028)10.73%
Revenue growth (FY2027)13.96%
Street view
Price target (mean)$244.14*
Target upside5.93%
Ratings (buy / hold / sell)22 / 7 / 1
FY2027 EPS revisions, 30d (up / down)25 / 0
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
period to 30 Apr 2026, filed 5 Jun 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
5Y CAGR +20.63%10Y CAGR +37.12%
Assumptions
As filed — not assumptions
Current price$230.47
Cash & equivalents$1.90B
Total debt—
Shares outstanding160.77M
Result
DCF price per share—
Current price$230.47
Margin of safety—
PV of years 1–10$31.68B
PV of terminal value$92.38B
Equity value—
Market-implied growth—
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $1.98B | $2.39B | $2.88B | $3.47B | $4.19B | $5.05B | $6.10B | $7.35B | $8.87B | $10.70B | $199.44B |
| PV | $1.83B | $2.05B | $2.29B | $2.55B | $2.85B | $3.18B | $3.56B | $3.97B | $4.44B | $4.96B | $92.38B |
period to 30 Apr 2026, filed 5 Jun 2026, close 7 Aug 2026